BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Sangart, Inc. 

11189 Sorrento Valley Road, Suite 104

San Diego  California    U.S.A.
Phone: 858-455-0966 Fax: 858-455-6963


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Sangart, Inc. Completes Patient Enrollment in Phase 2B Clinical Trial of MP4OX in Traumatic Hemorrhagic Shock Patients 10/9/2012 7:36:06 AM    More...
Sangart, Inc. Grabs $50 Million Series G Funding 5/25/2012 6:42:13 AM    More...
Sangart, Inc. Enhances Leadership Team Bringing Superior Depth of Expertise 2/15/2012 9:26:26 AM    More...
Sangart, Inc. Initiates Phase 1b Study of MP4CO in Patients With Sickle Cell Disease 1/13/2012 10:04:35 AM    More...
Sangart, Inc. Plans Extra Hiring at Irish Plant 8/23/2011 7:20:20 AM    More...
Pharma Firm Sangart, Inc. to Create 245 Jobs in Ireland 7/21/2011 8:14:43 AM    More...
Sangart, Inc. Initiates Phase 2b Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 6/14/2011 8:51:14 AM    More...
Sangart, Inc. Announces Closing of $50 Million Series G Financing 4/20/2011 7:04:08 AM    More...
Sangart, Inc. Announces Cooperative Research and Development Agreement With the U.S. Navy to Evaluate MP4 Molecule in Traumatic Brain Injury 12/6/2010 8:58:17 AM    More...
Sangart, Inc. Receives U.S. Orphan Drug Designation for use of MP4CO in Patients with Sickle Cell Disease 11/15/2010 10:18:15 AM    More...
1234